Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Simcere Pharmaceutical Group: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

13 Dec 2013 Reuters Investment Profile 12 $20.00

Trading Report for (SCR). A detailed report, including free correlated market analysis, and updates.

Detailed Trading Report for SCR. Entry levels, target prices, and risk controls are integral. In addition, free market analy...

28 Sep 2016 Stock Traders Daily 6 $20.00

Simcere Pharmaceutical Group

Simcere Pharmaceutical Group Summary Simcere Pharmaceutical Group (Simcere) is a pharmaceutical company that develops, ...

16 Sep 2016 GlobalData 37 $300.00

Simcere Pharmaceutical Group

Simcere Pharmaceutical Group Summary Simcere Pharmaceutical Group (Simcere) is a pharmaceutical company that develops, ...

27 Jun 2016 GlobalData 37 $300.00

Simcere Pharmaceuticals ADR

25 Dec 2013 S&P Capital IQ Quantitative Report 6 $69.00

ValuEngine Detailed Valuation Report for SCR

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

24 Dec 2013 ValuEngine, Inc. 11 $25.00

TheStreet.com Ratings Stock Report For: SIMCERE PHARMACTCL GRP -ADR (SCR)

22 Dec 2013 TheStreet.com Ratings 5 $10.00

SCR - Simcere Pharmaceutical Group - Rated a Hold - Company Analysis and ASR Ranking Report

www.AlphaStreetResearch.com - Full Coverage of 3,000 U.S. equities. Reports include Financials, Ratios, Competitor Comparison...

21 Dec 2013 Alpha Street Research 9 $24.00

Validea Guru Analysis Report for SCR. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.

Validea's Guru Stock Report uses an interpretation of the published stock-picking strategies developed by 10 investing legend...

20 Dec 2013 Validea 0 $12.00

SIMCERE PHARMAC (SCR) Zacks Company Snapshot

16 Dec 2013 Zacks Investment Research Inc. 1 $12.00